Wedgewood Partners’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-4,675
| Closed | -$322K | – | 39 |
|
2019
Q1 | $322K | Sell |
4,675
-2,925
| -38% | -$201K | 0.02% | 35 |
|
2018
Q4 | $453K | Sell |
7,600
-418,400
| -98% | -$24.9M | 0.03% | 28 |
|
2018
Q3 | $49.3M | Sell |
426,000
-297,494
| -41% | -$34.5M | 2.47% | 19 |
|
2018
Q2 | $91.3M | Sell |
723,494
-105,198
| -13% | -$13.3M | 4.61% | 12 |
|
2018
Q1 | $89.7M | Sell |
828,692
-95,070
| -10% | -$10.3M | 4.12% | 13 |
|
2017
Q4 | $101M | Sell |
923,762
-206,431
| -18% | -$22.6M | 4.1% | 14 |
|
2017
Q3 | $112M | Sell |
1,130,193
-132,071
| -10% | -$13M | 3.8% | 15 |
|
2017
Q2 | $128M | Sell |
1,262,264
-313,394
| -20% | -$31.7M | 3.91% | 13 |
|
2017
Q1 | $182M | Sell |
1,575,658
-70,666
| -4% | -$8.16M | 4.69% | 10 |
|
2016
Q4 | $198M | Sell |
1,646,324
-246,756
| -13% | -$29.6M | 4.82% | 8 |
|
2016
Q3 | $213M | Buy |
1,893,080
+205,653
| +12% | +$23.1M | 4.46% | 12 |
|
2016
Q2 | $209M | Sell |
1,687,427
-265,838
| -14% | -$32.9M | 4.24% | 14 |
|
2016
Q1 | $220M | Buy |
1,953,265
+17,391
| +0.9% | +$1.95M | 3.98% | 16 |
|
2015
Q4 | $211M | Sell |
1,935,874
-239,316
| -11% | -$26M | 3.61% | 17 |
|
2015
Q3 | $217M | Sell |
2,175,190
-174,502
| -7% | -$17.4M | 3.16% | 16 |
|
2015
Q2 | $268M | Sell |
2,349,692
-179,127
| -7% | -$20.4M | 3.59% | 15 |
|
2015
Q1 | $264M | Buy |
2,528,819
+307,944
| +14% | +$32.2M | 3.55% | 14 |
|
2014
Q4 | $267M | Buy |
+2,220,875
| New | +$267M | 3.6% | 13 |
|